Document is current
Any future updates will be listed below
-
Authors
Teede, Helena https://orcid.org/0000-0001-7609-577X
Morman, Rachel https://orcid.org/0000-0003-3551-352X
Dokras, Anuja https://orcid.org/0000-0002-1085-3969
Khomami, Mahnaz Bahri https://orcid.org/0000-0002-5955-1283
Piltonen, Terhi https://orcid.org/0000-0002-9921-7300
Norman, Robert https://orcid.org/0000-0002-3118-3896
Stener-Victorin, Elisabet https://orcid.org/0000-0002-3424-1502
- License Information
-
More Information
Article History
First Online: 22 May 2026
Competing interests
: H.T. is lead investigator on the Australian National Health and Medical Research Council (NHMRC)-funded Centre for Research Excellence in Women’s Health in Reproductive Life that funded the name change initiative (APP number 1171592). She is the president of the International Society of Endocrinology (honorary) and lead on the International PCOS Guidelines and is an advisor on the National Institute for Health and Care Excellence (NICE) Guidelines Committee. R.M. has received grants from Waterloo Foundation and Verity for administrative support, the All-Party Parliamentary Group and Roche Pharmaceuticals. She is an unpaid trustee of Verity and a member of the International Guidelines Steering Group and the NICE Guidelines Committee (honoraria). A.D. serves as executive director of the AE-PCOS Society. T.P. has received project grants from Novo Nordisk Foundation, the Research Council of Finland, and the Sigrid Juselius Foundation; consulting fees from Exeltis and Astellas; and honoraria from Exeltis and Gedeon Rich. E.S.-V. serves as chief scientific officer of the AE-PCOS Society; has received grants from Novo Nordisk Foundation, Swedish Research Council and Diabetes Foundation; and consulting fees from Exeltis and Alnyam.
